Quinolinic acid as trigger/biomarker of dysosmia/dysgeusia in patients with acute coronavirus disease 2019: A retrospective case-control study
Clinically, serum KTR and QUIN levels may serve as useful biomarkers for assessing dysgeusia/dysomia during acute COVID-19. Furthermore, vaccination may play an important preventive role, particularly against dysosmia.
Authors
- Yohei Miyagi (ORCID: https://orcid.org/0000-0002-0056-7010)
- Jun Tsukiji (ORCID: https://orcid.org/0000-0002-1578-3226)
- Hiroto Narimatsu (ORCID: https://orcid.org/0000-0002-0383-4911)
- Hiroyuki Takahashi
- Tomoko Takahashi
- Sachiyo Mitsunaga
- Sho Nakamura
- Shiro Koizume
- Shuji Murakami
Institutions
- Kanagawa Prefectural Hospital Organization (JP)
- Kanagawa Cancer Center
- Kanagawa University of Human Services (JP)
Publication Details
- Journal
- Brain Behavior & Immunity - Health
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1016/j.bbih.2026.101175
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00